United Therapeutics Corporation (NASDAQ:UTHR) — Market Cap & Net Worth

$21.42 Billion USD · Rank #1187

Market Cap & Net Worth: United Therapeutics Corporation (UTHR)

United Therapeutics Corporation (NASDAQ:UTHR) has a market capitalization of $21.42 Billion ($21.42 Billion) as of May 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #1187 globally and #477 in its home market, demonstrating a -0.43% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying United Therapeutics Corporation's stock price $570.40 by its total outstanding shares 43056599 (43.06 Million). Analyse UTHR cash flow metrics to see how efficiently the company converts income to cash.

United Therapeutics Corporation Market Cap History: 2015 to 2026

United Therapeutics Corporation's market capitalization history from 2015 to 2026. Data shows growth from $6.74 Billion to $24.56 Billion (15.33% CAGR).

Index Memberships

United Therapeutics Corporation is a constituent of 6 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
ARCA Biotechnology BTK	$910.33 Billion	2.35%	#11 of 30
Dow Jones Biotechnology DJUSBT	$1.09 Trillion	1.97%	#8 of 39
NASDAQ Health Care IXHC	$2.41 Trillion	0.89%	#16 of 976
NASDAQ Composite IXIC	$38.77 Trillion	0.06%	#135 of 3165
S&P Midcap 400 MID	$3.36 Trillion	0.50%	#13 of 401
NASDAQ Biotechnology NBI	$1.67 Trillion	1.28%	#10 of 263

Weight: United Therapeutics Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

United Therapeutics Corporation Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how United Therapeutics Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

5.28x

United Therapeutics Corporation's market cap is 5.28 times its annual revenue

Industry average: 1.04x Higher than industry average

Latest Price to Earnings (P/E) Ratio

12.71x

United Therapeutics Corporation's market cap is 12.71 times its annual earnings

Industry average: 8.30x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2015	$6.74 Billion	$1.47 Billion	$651.64 Million	4.60x	10.35x
2016	$6.18 Billion	$1.60 Billion	$713.70 Million	3.86x	8.65x
2017	$6.37 Billion	$1.73 Billion	$417.90 Million	3.69x	15.24x
2018	$4.69 Billion	$1.63 Billion	$589.20 Million	2.88x	7.96x
2019	$3.79 Billion	$1.45 Billion	-$104.50 Million	2.62x	N/A
2020	$6.54 Billion	$1.48 Billion	$514.80 Million	4.41x	12.70x
2021	$9.30 Billion	$1.69 Billion	$475.80 Million	5.52x	19.55x
2022	$11.97 Billion	$1.94 Billion	$727.30 Million	6.18x	16.46x
2023	$9.47 Billion	$2.33 Billion	$984.80 Million	4.07x	9.61x
2024	$15.19 Billion	$2.88 Billion	$1.20 Billion	5.28x	12.71x

Competitor Companies of UTHR by Market Capitalization

Companies near United Therapeutics Corporation in the global market cap rankings as of May 2, 2026.

Key companies related to United Therapeutics Corporation by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#499	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#525	Zoetis Inc	NYSE:ZTS	$50.31 Billion	$114.16
#526	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$50.29 Billion	CN¥53.88
#572	GALDERMA GROUP AG	NYSE:GALDY	$45.88 Billion	$42.09

United Therapeutics Corporation Historical Marketcap From 2015 to 2026

Between 2015 and today, United Therapeutics Corporation's market cap moved from $6.74 Billion to $ 24.56 Billion, with a yearly change of 15.33%.

Year	Market Cap	Change (%)
2026	$24.56 Billion	+17.07%
2025	$20.98 Billion	+38.09%
2024	$15.19 Billion	+60.46%
2023	$9.47 Billion	-20.93%
2022	$11.97 Billion	+28.70%
2021	$9.30 Billion	+42.35%
2020	$6.54 Billion	+72.33%
2019	$3.79 Billion	-19.12%
2018	$4.69 Billion	-26.39%
2017	$6.37 Billion	+3.15%
2016	$6.18 Billion	-8.42%
2015	$6.74 Billion	--

End of Day Market Cap According to Different Sources

On May 2nd, 2026 the market cap of United Therapeutics Corporation was reported to be:

Source	Market Cap
Yahoo Finance	$21.42 Billion USD
MoneyControl	$21.42 Billion USD
MarketWatch	$21.42 Billion USD
marketcap.company	$21.42 Billion USD
Reuters	$21.42 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About United Therapeutics Corporation

NASDAQ:UTHR USA Drug Manufacturers - Specialty & Generic

Market Cap

$24.56 Billion

Market Cap Rank

#1187 Global

#477 in USA

Share Price

$570.40

Change (1 day)

-0.17%

52-Week Range

$274.70 - $592.98

All Time High

$592.98